Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies - Correspondence

Int J Surg. 2022 Oct:106:106903. doi: 10.1016/j.ijsu.2022.106903. Epub 2022 Sep 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19* / prevention & control
  • Humans
  • Mutation
  • SARS-CoV-2 / genetics
  • Vaccines*

Substances

  • Vaccines

Supplementary concepts

  • SARS-CoV-2 variants